BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 24405607)

  • 1. Latent tuberculosis infection in a Malaysian prison: implications for a comprehensive integrated control program in prisons.
    Al-Darraji HA; Kamarulzaman A; Altice FL
    BMC Public Health; 2014 Jan; 14():22. PubMed ID: 24405607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of tuberculosis symptoms and latent tuberculous infection among prisoners in northeastern Malaysia.
    Margolis B; Al-Darraji HA; Wickersham JA; Kamarulzaman A; Altice FL
    Int J Tuberc Lung Dis; 2013 Dec; 17(12):1538-44. PubMed ID: 24200265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and correlates of latent tuberculosis infection among employees of a high security prison in Malaysia.
    Al-Darraji HA; Tan C; Kamarulzaman A; Altice FL
    Occup Environ Med; 2015 Jun; 72(6):442-7. PubMed ID: 25794506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active and latent tuberculosis in Brazilian correctional facilities: a cross-sectional study.
    Carbone Ada S; Paião DS; Sgarbi RV; Lemos EF; Cazanti RF; Ota MM; Junior AL; Bampi JV; Elias VP; Simionatto S; Motta-Castro AR; Pompílio MA; de Oliveira SM; Ko AI; Andrews JR; Croda J
    BMC Infect Dis; 2015 Jan; 15():24. PubMed ID: 25608746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and incidence rates of latent tuberculous infection in a large prison in Iran.
    Mamani M; Mahmudian H; Majzoobi MM; Poorolajal J
    Int J Tuberc Lung Dis; 2016 Aug; 20(8):1072-7. PubMed ID: 27393542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of latent tuberculosis infection and feasibility of TB preventive therapy among Thai prisoners: a cross-sectional study.
    Gatechompol S; Harnpariphan W; Supanan R; Suwanpimolkul G; Sophonphan J; Ubolyam S; Kerr SJ; Avihingsanon A; Kawkitinarong K
    BMC Public Health; 2021 Jun; 21(1):1206. PubMed ID: 34162348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of latent tuberculosis infection in inmates recently incarcerated in a men's prison in Barcelona.
    Marco A; Solé N; Orcau A; Escribano M; del Baño L; Quintero S; Caylà JA
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):60-4. PubMed ID: 22236847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of latent tuberculosis infection and associated risk factors in prison in East Wollega Zone of western Ethiopia.
    Chekesa B; Gumi B; Chanyalew M; Zewude A; Ameni G
    PLoS One; 2020; 15(5):e0233314. PubMed ID: 32428042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis screening in a novel substance abuse treatment center in Malaysia: implications for a comprehensive approach for integrated care.
    Al-Darraji HA; Wong KC; Yeow DG; Fu JJ; Loeliger K; Paiji C; Kamarulzaman A; Altice FL
    J Subst Abuse Treat; 2014 Feb; 46(2):144-9. PubMed ID: 24074846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensified pulmonary tuberculosis case finding among HIV-infected new entrants of a prison in Malaysia: implications for a holistic approach to control tuberculosis in prisons.
    Al-Darraji H; Hill P; Sharples K; Altice FL; Kamarulzaman A
    Int J Prison Health; 2023 Jan; ():. PubMed ID: 36622107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence and risk factors associated with latent tuberculous infection in two Colombian prisons.
    Rueda ZV; Arroyave L; Marin D; López L; Keynan Y; Giraldo MR; Pulido H; Arbeláez MP
    Int J Tuberc Lung Dis; 2014 Oct; 18(10):1166-71. PubMed ID: 25216829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthcare resources are inadequate to address the burden of illness among HIV-infected male prisoners in Malaysia.
    Bick J; Culbert G; Al-Darraji HA; Koh C; Pillai V; Kamarulzaman A; Altice F
    Int J Prison Health; 2016 Dec; 12(4):253-269. PubMed ID: 27921633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
    Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of mass-screening on tuberculosis incidence in a prospective cohort of Brazilian prisoners.
    Paião DS; Lemos EF; Carbone AD; Sgarbi RV; Junior AL; da Silva FM; Brandão LM; Dos Santos LS; Martins VS; Simionatto S; Motta-Castro AR; Pompílio MA; Urrego J; Ko AI; Andrews JR; Croda J
    BMC Infect Dis; 2016 Oct; 16(1):533. PubMed ID: 27716170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of Tuberculin Skin Test (TST) and T-SPOT.TB Tests for Diagnosis of Latent Tuberculosis Infection (LTBI) in HIV-infected Patients].
    Binay UD; Fincancı M; Fersan E; Karakeçili F
    Mikrobiyol Bul; 2019 Oct; 53(4):388-400. PubMed ID: 31709936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active and latent tuberculosis among inmates in La Esperanza prison in Guaduas, Colombia.
    Guerra J; Mogollón D; González D; Sanchez R; Rueda ZV; Parra-López CA; Murcia MI
    PLoS One; 2019; 14(1):e0209895. PubMed ID: 30682199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost analysis of tuberculin skin test and the QuantiFERON-TB Gold In-tube test for tuberculosis screening in a correctional setting in Dallas, Texas, USA.
    Nijhawan AE; Iroh PA; Brown LS; Winetsky D; Porsa E
    BMC Infect Dis; 2016 Oct; 16(1):564. PubMed ID: 27733123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative latent tuberculosis at time of incarceration: identifying a very high-risk group for infection.
    Arroyave L; Keynan Y; López L; Marin D; Arbeláez MP; Rueda ZV
    Epidemiol Infect; 2017 Sep; 145(12):2491-2499. PubMed ID: 28756786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of health-care workers for latent tuberculosis infection in a Tertiary Care Hospital.
    Janagond AB; Ganesan V; Vijay Kumar GS; Ramesh A; Anand P; Mariappan M
    Int J Mycobacteriol; 2017; 6(3):253-257. PubMed ID: 28776523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: a comparison of QuantiFERON-TB Gold In Tube, T-SPOT.TB and tuberculin skin test.
    Ramos JM; Robledano C; Masiá M; Belda S; Padilla S; Rodríguez JC; Gutierrez F
    BMC Infect Dis; 2012 Jul; 12():169. PubMed ID: 22849726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.